Orchard Capital Management’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-204,114
| Closed | -$3M | – | 45 |
|
|
2025
Q3 | $3M | Buy |
204,114
+5,995
| +3% | +$61.1K | 2.59% | 8 |
|
|
2025
Q2 | $1.95M | Sell |
198,119
-266,239
| -57% | -$2.2M | 2.15% | 15 |
|
|
2025
Q1 | $3.38M | Buy |
464,358
+421,733
| +989% | +$3.69M | 2.31% | 21 |
|
|
2024
Q4 | $333K | Buy |
42,625
+751
| +2% | +$6.18K | 0.13% | 43 |
|
|
2024
Q3 | $310K | Sell |
41,874
-697,334
| -94% | -$5.86M | 0.11% | 47 |
|
|
2024
Q2 | $5.92M | Sell |
739,208
-10,142
| -1% | -$90.6K | 1.79% | 28 |
|
|
2024
Q1 | $8.72M | Buy |
749,350
+10,142
| +1% | +$112K | 2.56% | 19 |
|
|
2023
Q4 | $8.26M | Buy |
739,208
+196,329
| +36% | +$1.8M | 2.59% | 20 |
|
|
2023
Q3 | $8.38M | Hold |
542,879
| – | – | 3.1% | 13 |
|
|
2023
Q2 | $10.3M | Sell |
542,879
-9,000
| -2% | -$158K | 3.46% | 8 |
|
|
2023
Q1 | $8.41M | Hold |
551,879
| – | – | 2.81% | 18 |
|
|
2022
Q4 | $7.03M | Hold |
551,879
| – | – | 2.35% | 22 |
|
|
2022
Q3 | $3.19M | Buy |
551,879
+383,386
| +228% | +$1.68M | 1.19% | 34 |
|
|
2022
Q2 | $592K | Buy |
168,493
+4,200
| +3% | +$12.7K | 0.18% | 39 |
|
|
2022
Q1 | $619K | Buy |
164,293
+14,100
| +9% | +$90.8K | 0.18% | 37 |
|
|
2021
Q4 | $1.96M | Hold |
150,193
| – | – | 0.58% | 33 |
|
|
2021
Q3 | $2.94M | Hold |
150,193
| – | – | 0.89% | 33 |
|
|
2021
Q2 | $2.81M | Buy |
+150,193
| New | +$3.35M | 0.81% | 33 |
|
Other funds holding ETNB
Orchard Capital Management's ETNB Position: Q4 2025 in Review
Orchard Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 204,114 shares — an estimated $3M sold.
Orchard Capital Management first reported a position in ETNB in Q2 2021 and held it in 18 quarters. The position peaked at $10.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Orchard Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Orchard Capital Management sold 204,114 89bio shares in Q4 2025, an estimated $3M.
- Orchard Capital Management first reported a position in 89bio in Q2 2021 and held it in 18 quarters.
- Orchard Capital Management's 89bio position peaked at $10.3M in Q2 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Orchard Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.